Frontlight ResearchEarly access
Trial site
Downtown L.A. Research Center, Inc.
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- High blood pressure3 trials
- Migraine2 trials
- Familial hypercholesterolaemia1 trial
- Gastroparesis1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Novartis Pharmaceuticals3 trials
- TriGemX Bio, Inc.2 trials
- CinDome Pharma, Inc.1 trial
Running trials
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Recruiting
Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Active, not recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure2 recruiting
- Migraine2 recruiting
- Familial hypercholesterolaemia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026